phenyl acetate has been researched along with Opioid-Related Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, N; Bansal, S; Kumar, M; Rehni, AK; Singh, I; Singh, N | 1 |
| Del Bianco, PL; Nicolodi, M; Sicuteri, F | 1 |
2 other study(ies) available for phenyl acetate and Opioid-Related Disorders
| Article | Year |
|---|---|
Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Topics: Acetates; Animals; Cyclopropanes; Female; Leukotriene Antagonists; Leukotriene D4; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Quinolines; Signal Transduction; Substance Withdrawal Syndrome; Sulfides; Tetrahydroisoquinolines | 2008 |
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse.
Topics: Acetates; Adult; Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Lamotrigine; Male; Middle Aged; Migraine Disorders; Opioid-Related Disorders; Substance Withdrawal Syndrome; Triazines | 1997 |